cell therapy

FDA proposes cell and gene therapy site tours to help regulators learn from industry
Fierce Pharma
Mon, 07/15/24 - 11:18 pm
cell therapy
gene therapy
FDA
CBER
OTP
Capricor’s cell therapy shows three year benefit in DMD patients
Clinical Trials Arena
Mon, 07/1/24 - 11:13 am
Capricor
deramiocel
cell therapy
DMD
clinical trials
Regenerative cell therapy biotech uses IPO to blast into human trials
Pharma Voice
Wed, 06/5/24 - 11:19 am
FibroBiologics
IPOs
cell therapy
regenerative cell therapy
Influx of adoptive cell therapies may be on the horizon
Clinical Trials Arena
Tue, 06/4/24 - 11:28 pm
cell therapy
Biotech faces a reckoning: ‘We've lost our luster in cell therapies’
Fierce Biotech
Wed, 05/29/24 - 09:23 pm
cell therapy
Gilead Sciences
Kite Pharma
FDA approves expanded use of Bristol Myers' cancer cell therapy
Reuters
Wed, 05/15/24 - 10:48 pm
Brisstol Myers Squibb
cell therapy
Breyanzi
follicular lymphoma
Cell and Gene Therapies Still Have Long Way to Go in Fulfilling Promise
BioSpace
Fri, 05/10/24 - 11:39 am
ASGCT
cell therapy
gene therapy
Cell therapy fails to slow early type 1 diabetes, but safety is established
Stat
Wed, 05/8/24 - 11:00 pm
type 1 diabetes
cell therapy
Astellas adds to ‘off-the-shelf’ cell therapy capabilities with Poseida deal
BioPharma Dive
Wed, 05/1/24 - 10:56 am
Astellas Pharma
Poseida Therapeutics
solid tumors
cell therapy
Bristol Myers Squibb closes immuno-oncology, cell therapy-focused Redwood City site
Fierce Biotech
Fri, 04/26/24 - 11:16 am
Bristol Myers Squibb
immuno-oncology
cell therapy
R&D
layoffs
Walgreens rolls out gene, cell therapy services
Beckers Hospital Review
Thu, 04/25/24 - 05:51 pm
Walgreens
cell therapy
gene therapy
Walgreens Specialty Pharmacy
Vertex Pharma Obtains Exclusive License To TreeFrog's Cell Manufacturing Technology, C-Stem
NASDAQ.com
Tue, 04/23/24 - 09:51 pm
Vertex Pharmaceuticals
TreeFrog Therapeutics
cell therapy
type 1 diabetes
Bristol Myers taps startup to boost cell therapy production
BioPharma Dive
Mon, 04/22/24 - 06:06 pm
Bristol Myers Squibb
drug manufacturing
cell therapy
Cellares
5 Cell and Gene Therapy Decisions to Watch in 2024
BioSpace
Mon, 04/22/24 - 11:38 am
cell therapy
gene therapy
Pfizer
Beqvez
hemophilia B
Abeona Therapeutics
pz-cel
recessive dystrophic epidermolysis bullosa
Rocket Pharmaceuticals
Kresladi
Leukocyte adhesion deficiency-1
Adaptimmune
afami-cel
advanced synovial sarcoma
Autolus Therapeutics
obe-cel
B cell acute lymphoblastic leukemia
Roche, Adaptimmune part ways on cell therapy research
BioPharma Dive
Sun, 04/14/24 - 01:26 pm
Roche
Genentech
cell therapy
cancer
Adaptimmune
FDA allows expanded use of Bristol Myers' cell therapy for blood cancer
Reuters
Fri, 04/5/24 - 11:40 am
Bristol Myers Squibb
2seventybio
Abecma
cell therapy
Capstan heats up ‘in vivo’ cell therapy chase with $175M fundraise
BioPharma Dive
Wed, 03/20/24 - 11:35 am
Capstan Therapeutics
cell therapy
funding
Gilead CAR-T cancer therapy capacity to quadruple by 2026
Reuters
Fri, 03/15/24 - 10:57 am
Gilead Sciences
cell therapy
cancer
drug manufacturing
J&J, Novo support Asgard’s push to make ‘in vivo’ cell therapies
BioPharma Dive
Thu, 03/14/24 - 11:31 am
Asgard Therapeutics
in vivo cell therapy
cell therapy
JNJ
Novo Nordisk
FDA staff raises concerns over data from J&J, Bristol's CAR-T therapies
Reuters
Wed, 03/13/24 - 10:46 am
FDA
JNJ
Bristol Myers Squibb
blood cancers
cell therapy

Pages